Biotech News
-
Voyageur Pharmaceuticals & Summit Nanotech Corporation Sign Memorandum of Understanding for a Technology Development Project
November 8, 2021 (Source) — Voyageur Pharmaceuticals Ltd. (TSXV:VM) (OTC:VYYRF) (the “Company” or “Voyageur”) is pleased to announce the signing of a…
-
Zentek Wins ISC Challenge to Develop a Portable Detection Device for SARS-CoV-2 in Wastewater
November 4, 2021 (Source) — Zentek Ltd. (“ZEN” or the “Company”) (TSX-V:ZEN)(OTC PINK:ZENYF), a Canadian, IP development and commercialization company…
-
Awakn Life Sciences Announces the Findings from the Phase II A/B Study Are to Be Published in the American Journal of Psychiatry
World’s First Controlled Study to Investigate Ketamine-Assisted Psychotherapy November 4, 2021 (Source) — Awakn Life Sciences Corp. (NEO: AWKN)…
-
Rritual Superfoods Shareholders Update
CEO, Warren Spence, Provides Key Areas of Focus for Growth in Letter to Shareholders November 3, 2021 (Source)…
-
Valeo Pharma Obtains Public Reimbursement For Enerzair® Breezhaler® and Atectura® Breezhaler® In Alberta
First provincial public listing secured for both asthma medications Additional provincial public reimbursement coverage expected to follow soon…
-
XPhyto Announces Managing Director Appointment, Financing and 3a-diagnostics Development
November 3, 2021 (Source) — NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE…
-
Zentek Develops New Carbon-Based Nanotechnology-Enhanced Icephobic Coating to Reduce Ice Accretion
Company anticipates applications for aircraft, wind turbines, ocean vessels, and building structures to increase safety and efficiency outcomes…
-
Awakn Life Sciences to Participate at the Wonderland: Miami Conference in November 2021
November 2, 2021 (Source) — Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (‘Awakn’), a biotechnology company…
-
DIAGNOS Delivers World Class Results in the MICCAI2021 Contest: GAMMA
October 28, 2021 (Source) — DIAGNOS Inc. (“DIAGNOS” or “the Company”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a…
-
Hemostemix Confirms OTCQB Listing
October 28, 2021 (Source) — Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) (“Hemostemix” or the “Company”) is pleased…
